Hims & Hers Health faces securities class action following FTC complaint
Investors have until November 2, 2026, to join a class action lawsuit against Hims & Hers Health, initiated after federal regulators challenged the company’s business practices.
Hims & Hers Health, Inc. is the subject of a securities class action lawsuit following a regulatory complaint filed by the Federal Trade Commission (FTC). Law firm Hagens Berman is representing investors who incurred losses, citing potential material misrepresentations regarding the company’s operational conduct.
The litigation centers on allegations that the telehealth provider engaged in business practices that drew scrutiny from federal authorities. The FTC complaint suggests the company’s actions may have misled stakeholders regarding the sustainability and legality of its growth strategy.
Investors seeking to participate in the suit must file by the November 2, 2026, deadline. The outcome of this legal action could impact the company’s market valuation and future regulatory standing.